Therapeutic Modalities and New Molecular Targets in MDS
Author:
Garcia-Manero Guillermo
Publisher
Springer Netherlands
Reference76 articles.
1. Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079–2088
2. Malcovati L, Germing U, Kuendgen A et al (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503–3510
3. Kantarjian H, O’Brien S, Ravandi F et al (2008) Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original international prognostic scoring system. Cancer 113:1351–1361
4. Garcia-Manero G, Shan J, Faderl S et al (2008) A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia 22:538–543
5. Rollison DE, Howlader N, Smith MT et al (2008) Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs. Blood 112:45–52